drugset / Trial / NCT00147745
Effects of Colesevelam on How the Body Responds to Insulin in Patients With Type 2 Diabetes
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is designed to assess the potential mechanism of action by which WelChol® (colesevelam) may improve blood glucose control in patients with type 2 diabetes
Timeline
- Start
- 2005-06
- Primary completion
- 2008-01
- Completion
- 2008-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Colesevelam | Other / unclassified | 3.8 g | — |
| Comparator | insulin glargine | Protein / enzyme biologic | — | — |